Blood Volume Assessment in COVID-19 and Bacterial Sepsis

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

April 9, 2023

Study Completion Date

April 9, 2023

Conditions
Covid19Acute Respiratory Distress SyndromeBacterial SepsisBacterial Infections
Interventions
DEVICE

BVA-100

The BVA-100 is a software package designed to calculate human blood volume using the method of tracer dilution. It uses tagged serum albumin.

DEVICE

Transpulmonary Thermodilution (TPTD)

TPTD consists of placing a thermistor-equipped catheter in a central artery (usually the femoral or axillary artery) and injecting cold saline solution into a central vein through a central venous catheter.

DEVICE

Sublingual Microcirculation

With incident dark field imaging, the CytoCam device can record digital image sequences using a handheld camera. In the current study the camera will be used to non-invasively record images of the sublingual microcirculation.

Trial Locations (3)

10016

NYU Langone Health, New York

20814

Uniformed Services University of the Health Sciences, Bethesda

27157

Wake Forest Baptist Health, Winston-Salem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Daxor Corporation

INDUSTRY

lead

NYU Langone Health

OTHER